Published in Drug Week, January 7th, 2005
The phase III trial will be conducted at four centers in the U.S., including the University of Rochester Medical Center, the University of Maryland School of Medicine, Baltimore, Maryland, Cincinnati (Ohio) Children's Hospital, and Baylor College of Medicine.
The randomized, double-blind, placebo-controlled trial will involve approximately 1000...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.